Glaucoma Trials Tracker
Access <I>Glaucoma Physician's</i> listing of all active interventional clinical trials related to glaucoma.
Clinical Scorecard: Glaucoma Trials Tracker
At a Glance
Category Detail
Condition Glaucoma Key Mechanisms Intraocular pressure reduction through various interventions including medications, surgical techniques, and devices. Target Population Patients with open-angle glaucoma or ocular hypertension, including those with refractory cases. Care Setting Clinical trials across various healthcare institutions.
Key Highlights
Multiple trials evaluating new treatments for intraocular pressure reduction. Focus on both pharmacological and surgical interventions. Involvement of various sponsors including AbbVie, Glaukos Corporation, and Bausch + Lomb. Guideline-Based Recommendations
Diagnosis
Diagnosis of glaucoma should include assessment of intraocular pressure, visual field testing, and optic nerve evaluation. Management
Consider both medical and surgical options based on the severity and type of glaucoma. Monitoring & Follow-up
Regular follow-up to monitor intraocular pressure and visual field changes. Risks
Potential risks include progression of glaucoma, side effects from medications, and complications from surgical interventions. Patient & Prescribing Data
Adults with open-angle glaucoma or ocular hypertension.
Emerging therapies include fixed-dose combinations and novel surgical techniques.
Clinical Best Practices
Utilize a multidisciplinary approach for managing glaucoma patients. Incorporate patient education regarding treatment options and adherence. Related Resources & Content
